Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Reporter Gene Assay Market - COVID19 Impact & Revenue Growth Expectations

 



(PharmaNewsWire.Com, August 27, 2020 ) The reporter gene assay market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%.



By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)”



Based on application, the Reporter Gene Assay Market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).



Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20053198



Assay kits segment to witness the highest growth during the forecast period



On the basis of product, the market is broadly classified into assay kits and reagents. The assay kits segment is estimated to hold the largest share of the market in 2019 and is also projected to grow at the highest rate during the forecast period. The large share and high growth rate of the assay kits segment can be attributed to their repeated use in Gene Expression studies and signaling pathway analysis during gene transcription or translation levels. Moreover, assay kits are preferred over standalone reagents in cases where a validated protocol for assay development is available.



COVID19 Impact Analysis:



# Covid Impact on Reporter Gene Assay Market, growth/decline in product type/use cases of Reporter Gene Assay Market due to cascaded impact of Covid on Extended Ecosystem.



# How top 50 companies in Reporter Gene Assay Market are making rapid shifts in their strategies as we speak here.



# Outside-in view of top 50 companies client and client's clients shifting short-term priorities



North America to hold the largest regional market share in 2019



North America is expected to account for the largest share of the reporter gene assay market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.



Critical questions the report answers:



# Where will all these developments take the industry in the mid-to-long term?

# What are the major end users of reporter gene assays?

# What are the application areas of the reporter gene assays?

# Which are the most commonly used reporter gene assays kits?

# What is the global scenario of the reporter gene assays market?



Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=20053198



Players in the global reporter gene assay market, such as Merck KGaA (Germany), Thermo Fisher Scientific (US), Promega Corporation (US), Abcam plc (UK), PerkinElmer (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Geno Technology (US), GeneCopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), and Biotium (US) are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies of product launches, expansions, agreements, collaborations, and acquisitions.



About MarketsandMarkets™



MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.



Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.



MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com

MarketsandMarkets™

Mr. Aashish Mehra

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC